The regulatory role of Nrf2 in antioxidants phase2 enzymes and IL-17A expression in patients with ulcerative colitis
- 1 August 2018
- journal article
- research article
- Published by Elsevier BV in Pathology - Research and Practice
- Vol. 214 (8), 1149-1155
- https://doi.org/10.1016/j.prp.2018.06.001
Abstract
No abstract availableKeywords
Funding Information
- Shahrekord University of Medical Sciences (2337)
This publication has 35 references indexed in Scilit:
- Oxidative stress in ulcerative colitis: an old concept but a new concernFree Radical Research, 2012
- Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitisScientific Reports, 2011
- Multiple Functions of Peroxiredoxins: Peroxidases, Sensors and Regulators of the Intracellular Messenger H2O2, and Protein ChaperonesAntioxidants and Redox Signaling, 2011
- Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stressBiochemical and Biophysical Research Communications, 2011
- Hemin Exerts Multiple Protective Mechanisms and Attenuates Dextran Sulfate Sodium–induced ColitisJournal of Pediatric Gastroenterology and Nutrition, 2010
- Decoy oligodeoxynucleotide targeting activator protein-1 (AP-1) attenuates intestinal inflammation in murine experimental colitisLaboratory Investigation, 2008
- Molecular Basis of Epithelial Barrier Regulation: From Basic Mechanisms to Clinical ApplicationThe American Journal of Pathology, 2006
- The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsGut, 2006
- Regulation of reactive oxygen species, DNA damage and c-Myc function by peroxiredoxin 1Oncogene, 2005
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisThe New England Journal of Medicine, 1987